Results 41 to 50 of about 24,788 (241)

Elimination Profile of Deflazacort and Metabolites in Urine and Plasma Following Oral Administration: Relevance to Sports Drug Testing

Drug Testing and Analysis, EarlyView.
Results confirm that the MRL of 30 ng/mL for 21‐desacetyl‐deflazacort together with a 3‐day washout period is an appropriated strategy to detect oral deflazacort administration in sport competition. ABSTRACT Deflazacort (DEF) is a glucocorticoid prohibited in sports competitions when orally administered.
Sergi Coll, Claudia Bressan, Núria Monfort, Ana Aldea‐Perona, Marcel·lí Carbó, Rosa Ventura   +5 more
wiley   +1 more source

Beyond Gut Modulation: A Critical Review of the Therapeutic Potential, Safety, and Clinical Prospects of Natural Polysaccharides for IBD

Food Safety and Health, EarlyView.
In this review, we critically summarized the application of natural polysaccharides (NPs) for the treatment of IBD. This approach combines, in a unique way (right), the basic structure–activity relationships of NPs from different origins (left) with their multipronged mode of action, which involves modulation of the gut microbiota and other ...
Felix Danso, A. M. Abd El‐Aty, Kwaku Amoah, Xianghong Ju   +3 more
wiley   +1 more source

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis [PDF]

, 2006
Background: Rectal budesonide is an effective treatment of active ulcerative proctitis or proctosigmoiditis. Aim: To compare the therapeutic efficacy, tolerability and safety, and patient's preference of budesonide foam vs. budesonide enema.
Pronai, L., Müller, R., Mickisch, O., Kovács, Á, Tulassay, Z., Gross, V., Kiudelis, G., Greinwald, R., Bar-Meir, S., Stolte, M., Razbadauskas, A., Faszczyk, M., Lavy, A., Margus, B., Pokrotnieks, J., Kupcinskas, L.   +15 more
core   +1 more source

Budesonide MMX versus prednisolone in mesalamine-refractory mild to moderate ulcerative colitis: a randomized controlled clinical trial

The Egyptian Journal of Internal Medicine
Background Recently licensed to treat mild or moderate ulcerative colitis (UC), Budesonide MMX is a corticosteroid of the second generation designed to distribute pharmacologically active drugs throughout the colon.
Ashraf M. Osman, Mohammed A. Medhat, Ghada M. Kamal   +2 more
doaj   +1 more source

The Combination Therapy of Dietary Galacto-Oligosaccharides With Budesonide Reduces Pulmonary Th2 Driving Mediators and Mast Cell Degranulation in a Murine Model of House Dust Mite Induced Asthma

Frontiers in Immunology, 2018
Background: Dietary non-digestible galacto-oligosaccharides (GOS) suppress allergic responses in mice sensitized and challenged with house dust mite (HDM).
Kim A. T. Verheijden, Kim A. T. Verheijden, Saskia Braber, Thea Leusink-Muis, Prescilla V. Jeurink, Suzan Thijssen, Aletta D. Kraneveld, Johan Garssen, Johan Garssen, Gert Folkerts, Linette E. M. Willemsen   +10 more
doaj   +1 more source

Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands [PDF]

, 2006
Objective: Inhaled corticosteroids (ICS) are widely used in the treatment of asthma. We studied the suspected adverse drug reactions (sADRs) reported during the use of ICS in the Netherlands. Methods: In the Netherlands, health professionals and patients
van Puijenbroek, E; id_orcid, van Puijenbroek, E, de Vries, T.W., de Jong-van den Berg, L.T.W., de Langen-Wouterse, J J, L. T. W. de Jong-Van den Berg, T. W. de Vries, E. J. Duiverman, J. J. de Langen-Wouterse, de Jong-Van den Berg, L T W, Langen-Wouterse, J.J., van Puijenbroek, E., Duiverman, E.J., Duiverman, E J, E. van Puijenbroek   +14 more
core   +1 more source

Outcomes and adverse effects of teduglutide treatment with periodic withdrawal in pediatric short bowel patients

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives We evaluated the efficacy and safety of teduglutide in a real‐world cohort in which national reimbursement policies required treatment interruptions. The primary outcomes were reduction in parenteral support (PS) and treatment‐related adverse effects, and the secondary outcome was the impact of the mandated withdrawal periods ...
Riikka Gunnar, Annika Mutanen, Mikko P. Pakarinen, Laura Merras‐Salmio   +3 more
wiley   +1 more source

Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis

JPGN Reports, EarlyView.
Abstract We describe a pediatric patient treated with upadacitinib for atopic dermatitis (AD) who subsequently achieved sustained clinical and histologic remission of eosinophilic esophagitis (EoE). Upadacitinib is an oral small molecule selective Janus kinase 1 inhibitor that inhibits janus kinase‐signal transduction and activation of transcription ...
Nathalie Nguyen, Maureen Bauer
wiley   +1 more source

Comparative efficacy of Budesonide by different delivery devices in Bronchial Asthma

National Journal of Physiology, Pharmacy and Pharmacology, 2012
Aims& Objective: To assess the relative efficiency of budesonide administered from different delivery devices to adult patients of chronic stable bronchial asthma as measured by pulmonary function test parameters. Materials and Methods: This prospective
Dilshad Ali Rizvi, Mohammad Tariq Salman, Syed Esam Mahmood, Joydeep Sircar, Karim Ullah Ansari, Vinod Kumar Verma   +5 more
doaj   +1 more source

Grafting biomaterials associated to topical glucocorticoid: effects on pre-osteoblastic cells (MC3T3-E1)

Brazilian Oral Research, 2022
The topical glucocorticoid budesonide has been prescribed before and after sinus lift surgery as adjuvant drug treatment for maxillary sinus membrane inflammation.
Alice de Araújo Ferreira SILVA, Carolina Nemesio de Barros PEREIRA, Danilo Rocha DIAS, Frederico Santos LAGES, Katia Lucy Melo MALTOS, Allyson Nogueira MOREIRA, Elton Gonçalves ZENÓBIO, Ivana Márcia Alves DINIZ   +7 more
doaj   +1 more source